SecSonar.com

AxoGen, Inc. (AXGN)

AxoGen, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

AxoGen, Inc. (AXGN) is a Medical - Devices company based in US with a market capitalization of $2.1B. Revenue grew 20.2% year-over-year and free cash flow was negative at -$2.9M. This page tracks AXGN's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 451 employees · IPO Dec 17, 1986

Valuation

Valuation & price

$40.99 · as of May 17, 2026 · -11.3% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

16.22

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$45.72$28.54$11.36Jul 25Dec 25Jul 26Jul 7, 25$11.36Jul 9, 25$11.76Jul 11, 25$11.89Jul 15, 25$11.67Jul 17, 25$11.63Jul 21, 25$11.61Jul 23, 25$13.46Jul 25, 25$13.37Jul 29, 25$13.43Jul 31, 25$13.09Aug 4, 25$12.55Aug 6, 25$13.75Aug 11, 25$14.01Aug 13, 25$14.76Aug 15, 25$14.93Aug 19, 25$15.36Aug 21, 25$15.84Aug 25, 25$14.79Aug 27, 25$16.14Aug 29, 25$16.14Sep 3, 25$15.61Sep 5, 25$15.98Sep 9, 25$16.42Sep 11, 25$16.80Sep 16, 25$16.73Sep 18, 25$17.26Sep 22, 25$17.60Sep 24, 25$17.39Sep 26, 25$17.16Sep 30, 25$17.84Oct 2, 25$17.88Oct 6, 25$17.16Oct 8, 25$17.16Oct 10, 25$15.99Oct 14, 25$15.87Oct 16, 25$16.74Oct 21, 25$17.49Oct 23, 25$18.05Oct 27, 25$17.77Oct 29, 25$22.25Oct 31, 25$22.22Nov 4, 25$23.77Nov 6, 25$23.99Nov 10, 25$24.00Nov 12, 25$24.09Nov 14, 25$23.55Nov 18, 25$24.01Nov 20, 25$25.67Nov 25, 25$28.32Nov 28, 25$28.65Dec 2, 25$27.69Dec 4, 25$32.85Dec 8, 25$30.79Dec 10, 25$30.01Dec 12, 25$30.39Dec 16, 25$29.35Dec 18, 25$31.70Dec 22, 25$32.74Dec 24, 25$32.64Dec 29, 25$33.45Jan 2, 26$31.00Jan 6, 26$31.05Jan 8, 26$33.37Jan 12, 26$31.55Jan 14, 26$30.80Jan 16, 26$31.02Jan 21, 26$33.01Jan 23, 26$32.83Jan 27, 26$34.59Jan 29, 26$34.00Feb 2, 26$35.02Feb 4, 26$34.22Feb 9, 26$33.93Feb 11, 26$33.90Feb 13, 26$33.23Feb 18, 26$35.25Feb 20, 26$35.30Feb 24, 26$32.50Feb 26, 26$31.90Mar 2, 26$30.65Mar 4, 26$29.22Mar 6, 26$28.55Mar 10, 26$30.69Mar 12, 26$31.76Mar 17, 26$32.75Mar 19, 26$31.16Mar 23, 26$31.75Mar 25, 26$33.28Mar 27, 26$31.28Mar 31, 26$33.13Apr 2, 26$34.44Apr 7, 26$30.99Apr 9, 26$33.02Apr 13, 26$33.47Apr 15, 26$34.76Apr 17, 26$38.50Apr 22, 26$37.00Apr 24, 26$39.25Apr 28, 26$41.99Apr 30, 26$43.20May 4, 26$42.63May 6, 26$43.48May 8, 26$42.06May 12, 26$40.93May 14, 26$40.95May 18, 26$41.95May 20, 26$42.69May 22, 26$40.90May 28, 26$40.42Jun 1, 26$38.72Jun 3, 26$40.63Jun 5, 26$42.80Jun 9, 26$42.87Jun 11, 26$42.36Jun 15, 26$43.74Jun 17, 26$44.57Jun 22, 26$44.95Jun 24, 26$42.52Jun 26, 26$44.93Jul 2, 26$45.72
$11.2852-week range$46.19
Loading valuation history…

Fundamentals

Key fundamentals

$2.1B

Market cap

20.2%

Revenue growth (YoY)

74.3%

Gross margin

-$2.9M

Free cash flow (USD)

-$16.3M

Net debt

Net cash position

4.0%

Share dilution

1/5

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$41.1MFY 2017$60.4MFY 2018$83.9MFY 2019$106.7MFY 2020$112.3MFY 2021$127.4MFY 2022$138.6MFY 2023$159.0MFY 2024$187.3MFY 2025$225.2M
$41.1M$225.2M

Free cash flow by year

2016 → 2025

FY 2016$-12.4MFY 2017$-10.5MFY 2018$-24.5MFY 2019$-25.1MFY 2020$-32.2MFY 2021$-41.8MFY 2022$-37.3MFY 2023$-20.6MFY 2024$11.0KFY 2025$-2.9M
-$12.4M-$2.9M

Gross margin by year

2021 → 2025

FY 202182.0%FY 202278.5%FY 202376.6%FY 202475.8%FY 202574.3%
82.0%74.3%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 10-Q filed Apr 28, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 8-K eventAnnual Meeting ResultsJun 23, 2026Filing
  • 8-K eventEarnings ReleaseApr 28, 2026Filing
  • Quarterly report10-Q FiledApr 28, 2026Filing

Questions

Frequently asked questions

What is AxoGen, Inc.'s market cap?

AxoGen, Inc. (AXGN) has a market capitalization of $2.1B.

What is AXGN's P/E ratio?

A meaningful P/E ratio is not available for AXGN — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

What is AXGN's price-to-book (P/B) ratio?

AXGN trades at 16.22 times book value per share.

Are insiders buying AXGN stock?

SEC Form 4 filings show no open-market insider buys at AxoGen, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Medical - Devices

ESTA

Establishment Labs Holdings Inc.

$2.1B

TMDX

TransMedics Group, Inc.

$2.3B

UFPT

UFP Technologies, Inc.

$1.7B

PRCT

PROCEPT BioRobotics Corporation

$1.5B

AHCO

AdaptHealth Corp.

$1.4B

ENOV

Enovis Corporation

$1.3B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.